Pfizer Stomach Cancer Pill Wins EU 'Orphan' Status (Reuters
Reuters - Pfizer Inc's experimental drug for a
deadly form of stomach cancer has been recommended for
so-called orphan drug status in the European Union, the
European Medicines Agency said.
Read more...